COMPONENT SUPPLY CO INC

Component Supply Co Inc specializes in the design, prototyping, and material supply for highly specialized medical devices, with demonstrated expertise in custom catheter systems for invasive cardiac interventions. Their core capabilities center on precision engineering of microcatheter components and iterative prototyping for deep intramyocardial ablation systems, supporting advanced electrophysiology research. The contractor delivers engineered materials and component iterations that enable researchers to refine minimally invasive catheter navigation technologies, particularly for ventricular tachycardia ablation applications. Their technical proficiency lies in high-tolerance polymer and composite material selection, microfabrication support, and rapid prototyping workflows aligned with biomedical research timelines. Key differentiators include the ability to translate complex clinical requirements into manufacturable prototypes with consistent mechanical and biocompatible properties under tight experimental constraints. The company has delivered services to the Department of Health and Human Services, specifically supporting the National Institutes of Health’s National Heart, Lung, and Blood Institute. Their engagement involves direct collaboration with laboratory-based research teams developing next-generation cardiac ablation platforms, indicating a focused relationship rooted in translational medical device innovation rather than broad procurement. The primary NAICS code of 541715 reflects their role in physical and engineering research support, particularly in the development of novel biomedical instrumentation. This positions them within the niche market of research-enabling suppliers for academic and government biomedical labs, rather than commercial medical device manufacturing. Component Supply Co Inc is a small business structured as a 2L entity, headquartered in Sparta, Tennessee. While currently holding no federal certifications, their geographic presence and specialized technical output indicate a targeted positioning within the U.S. government’s biomedical R&D supply chain, serving high-precision research needs through agile, contract-based prototyping support.